The impact of 2 weeks wait referral on survival of head and neck cancer patients

PURPOSE: This study aims to evaluate the association between 2 weeks wait referral and survival in the head and neck cancer. METHODS: Retrospective cohort study of consecutively discussed new head and neck cancer patients at large United Kingdom Cancer Alliance including two tertiary referral hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rovira, Aleix, Russell, Beth, Trivedi, Priyanka, Ojo, Onaiho, Oakley, Richard, Byrne, Edie, Daryanani, Avisha, Van Hemelrijck, Mieke, Simo, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Head and Neck
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620249/
https://www.ncbi.nlm.nih.gov/pubmed/37526700
http://dx.doi.org/10.1007/s00405-023-08152-0
_version_ 1785130166809264128
author Rovira, Aleix
Russell, Beth
Trivedi, Priyanka
Ojo, Onaiho
Oakley, Richard
Byrne, Edie
Daryanani, Avisha
Van Hemelrijck, Mieke
Simo, Ricard
author_facet Rovira, Aleix
Russell, Beth
Trivedi, Priyanka
Ojo, Onaiho
Oakley, Richard
Byrne, Edie
Daryanani, Avisha
Van Hemelrijck, Mieke
Simo, Ricard
author_sort Rovira, Aleix
collection PubMed
description PURPOSE: This study aims to evaluate the association between 2 weeks wait referral and survival in the head and neck cancer. METHODS: Retrospective cohort study of consecutively discussed new head and neck cancer patients at large United Kingdom Cancer Alliance including two tertiary referral hospitals and two district general hospital. RESULTS: A total of 276 cancer patients were included for analysis. Patients referred under the 2 weeks wait had were seen and diagnosed sooner from referral (p < 0.0001 and p < 0.0001 respectively). However, this did not translate into better survival outcomes. No survival differences were seen between those patients that were managed within the proposed cancer targets and those that were not. CONCLUSIONS: The 2 weeks wait head and neck cancer pathway did not offer a survival advantage. Targeting the delay in referral as well as delay in treatment to prevent late-stage cancer presentation is paramount. Fulfilment of cancer time targets do not translate into better outcomes and should not be prioritised to clinical judgement.
format Online
Article
Text
id pubmed-10620249
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-106202492023-11-03 The impact of 2 weeks wait referral on survival of head and neck cancer patients Rovira, Aleix Russell, Beth Trivedi, Priyanka Ojo, Onaiho Oakley, Richard Byrne, Edie Daryanani, Avisha Van Hemelrijck, Mieke Simo, Ricard Eur Arch Otorhinolaryngol Head and Neck PURPOSE: This study aims to evaluate the association between 2 weeks wait referral and survival in the head and neck cancer. METHODS: Retrospective cohort study of consecutively discussed new head and neck cancer patients at large United Kingdom Cancer Alliance including two tertiary referral hospitals and two district general hospital. RESULTS: A total of 276 cancer patients were included for analysis. Patients referred under the 2 weeks wait had were seen and diagnosed sooner from referral (p < 0.0001 and p < 0.0001 respectively). However, this did not translate into better survival outcomes. No survival differences were seen between those patients that were managed within the proposed cancer targets and those that were not. CONCLUSIONS: The 2 weeks wait head and neck cancer pathway did not offer a survival advantage. Targeting the delay in referral as well as delay in treatment to prevent late-stage cancer presentation is paramount. Fulfilment of cancer time targets do not translate into better outcomes and should not be prioritised to clinical judgement. Springer Berlin Heidelberg 2023-08-01 2023 /pmc/articles/PMC10620249/ /pubmed/37526700 http://dx.doi.org/10.1007/s00405-023-08152-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Head and Neck
Rovira, Aleix
Russell, Beth
Trivedi, Priyanka
Ojo, Onaiho
Oakley, Richard
Byrne, Edie
Daryanani, Avisha
Van Hemelrijck, Mieke
Simo, Ricard
The impact of 2 weeks wait referral on survival of head and neck cancer patients
title The impact of 2 weeks wait referral on survival of head and neck cancer patients
title_full The impact of 2 weeks wait referral on survival of head and neck cancer patients
title_fullStr The impact of 2 weeks wait referral on survival of head and neck cancer patients
title_full_unstemmed The impact of 2 weeks wait referral on survival of head and neck cancer patients
title_short The impact of 2 weeks wait referral on survival of head and neck cancer patients
title_sort impact of 2 weeks wait referral on survival of head and neck cancer patients
topic Head and Neck
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620249/
https://www.ncbi.nlm.nih.gov/pubmed/37526700
http://dx.doi.org/10.1007/s00405-023-08152-0
work_keys_str_mv AT roviraaleix theimpactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT russellbeth theimpactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT trivedipriyanka theimpactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT ojoonaiho theimpactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT oakleyrichard theimpactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT byrneedie theimpactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT daryananiavisha theimpactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT vanhemelrijckmieke theimpactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT simoricard theimpactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT roviraaleix impactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT russellbeth impactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT trivedipriyanka impactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT ojoonaiho impactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT oakleyrichard impactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT byrneedie impactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT daryananiavisha impactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT vanhemelrijckmieke impactof2weekswaitreferralonsurvivalofheadandneckcancerpatients
AT simoricard impactof2weekswaitreferralonsurvivalofheadandneckcancerpatients

Ejemplares similares